New

Cyanocobalamin Injection Market

2021

Cyanocobalamin Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Vitamins, Supplements); End User (Hospitals, Clinics, others)

| Report Code: TIPRE00021886 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Cyanocobalamin Injection Market 2028 By Type, End User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Cyanocobalamin is the synthetic form of vitamin B12. The deficiency of vitamin B12 is due to the fact that pure vegan products contain less amount of B12, which make vegan people more susceptible towards anemia as vitamin B12 helps in the maturation of the red blood cells in the bone marrow. In the global cyanocobalamin market, Europe and the Asia Pacific held the major share in the consumption of cyanocobalamin. On the other hand, North America, and Europe account for major share in the production of cyanocobalamin owing to the presence of a global player in the region. The attractive marketing strategies and unique promotional activities by cyanocobalamin manufacturers have led to bringing awareness about the cyanocobalamin among the regional customers. With the increasing demand of cyanocobalamin in the market, it can be anticipated that the demand for cyanocobalamin will increase over the forecast period.

MARKET DYNAMICS

Cyanocobalamin Injection market is driving due to factors such as increasing veganism has uplifted the deficiency of certain vitamins such as vitamin B12 among vegan consumers and increasing awareness about the cyanocobalamin supplement. However, Lack of efficacy and stringent regulations are likely to create a negative impact on the growth of this market.

MARKET SCOPE

The Cyanocobalamin Injection market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Cyanocobalamin Injection Market with detailed market segmentation by type and end user. The Cyanocobalamin Injection Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Cyanocobalamin Injection market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Cyanocobalamin Injection market is segmented based on type and end user. Based on type, market is segmented as vitamins and supplements. Based on end user, market is segmented as hospital, clinics and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Cyanocobalamin Injection market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cyanocobalamin Injection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Cyanocobalamin Injection market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cyanocobalamin Injection market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Cyanocobalamin Injection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Application and End user launches, Application and End user approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Cyanocobalamin Injection market are anticipated to have lucrative growth opportunities in the future with the rising demand for Cyanocobalamin Injection in the global market. Below mentioned is the list of few companies engaged in the Cyanocobalamin Injection Market.

The report also includes the profiles of key players in Cyanocobalamin Injection market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Luitpold Pharmaceuticals (Daiichi Sankyo)
  •   Endo International
  •   Bristol-Myers Squibb
  •   Sanofi-Aventis
  •   Jamieson
  •   Teva (Actavis)
  •   Merck
  •   Mylan
  •   Bayer HealthCare
  •   Pfizer
  •   ANGELINI
  •   Biological E
  •   CCEPCD
  •   Huaxin Pharmaceutical

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cyanocobalamin Injection Market - By Type
1.3.2 Cyanocobalamin Injection Market - By End User
1.3.3 Cyanocobalamin Injection Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CYANOCOBALAMIN INJECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CYANOCOBALAMIN INJECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CYANOCOBALAMIN INJECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. CYANOCOBALAMIN INJECTION - GLOBAL MARKET OVERVIEW
6.2. CYANOCOBALAMIN INJECTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CYANOCOBALAMIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. VITAMINS
7.3.1. Overview
7.3.2. Vitamins Market Forecast and Analysis
7.4. SUPPLEMENTS
7.4.1. Overview
7.4.2. Supplements Market Forecast and Analysis
8. CYANOCOBALAMIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. others Market Forecast and Analysis
9. CYANOCOBALAMIN INJECTION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cyanocobalamin Injection Market Overview
9.1.2 North America Cyanocobalamin Injection Market Forecasts and Analysis
9.1.3 North America Cyanocobalamin Injection Market Forecasts and Analysis - By Type
9.1.4 North America Cyanocobalamin Injection Market Forecasts and Analysis - By End User
9.1.5 North America Cyanocobalamin Injection Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cyanocobalamin Injection Market
9.1.5.1.1 United States Cyanocobalamin Injection Market by Type
9.1.5.1.2 United States Cyanocobalamin Injection Market by End User
9.1.5.2 Canada Cyanocobalamin Injection Market
9.1.5.2.1 Canada Cyanocobalamin Injection Market by Type
9.1.5.2.2 Canada Cyanocobalamin Injection Market by End User
9.1.5.3 Mexico Cyanocobalamin Injection Market
9.1.5.3.1 Mexico Cyanocobalamin Injection Market by Type
9.1.5.3.2 Mexico Cyanocobalamin Injection Market by End User
9.2. EUROPE
9.2.1 Europe Cyanocobalamin Injection Market Overview
9.2.2 Europe Cyanocobalamin Injection Market Forecasts and Analysis
9.2.3 Europe Cyanocobalamin Injection Market Forecasts and Analysis - By Type
9.2.4 Europe Cyanocobalamin Injection Market Forecasts and Analysis - By End User
9.2.5 Europe Cyanocobalamin Injection Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cyanocobalamin Injection Market
9.2.5.1.1 Germany Cyanocobalamin Injection Market by Type
9.2.5.1.2 Germany Cyanocobalamin Injection Market by End User
9.2.5.2 France Cyanocobalamin Injection Market
9.2.5.2.1 France Cyanocobalamin Injection Market by Type
9.2.5.2.2 France Cyanocobalamin Injection Market by End User
9.2.5.3 Italy Cyanocobalamin Injection Market
9.2.5.3.1 Italy Cyanocobalamin Injection Market by Type
9.2.5.3.2 Italy Cyanocobalamin Injection Market by End User
9.2.5.4 Spain Cyanocobalamin Injection Market
9.2.5.4.1 Spain Cyanocobalamin Injection Market by Type
9.2.5.4.2 Spain Cyanocobalamin Injection Market by End User
9.2.5.5 United Kingdom Cyanocobalamin Injection Market
9.2.5.5.1 United Kingdom Cyanocobalamin Injection Market by Type
9.2.5.5.2 United Kingdom Cyanocobalamin Injection Market by End User
9.2.5.6 Rest of Europe Cyanocobalamin Injection Market
9.2.5.6.1 Rest of Europe Cyanocobalamin Injection Market by Type
9.2.5.6.2 Rest of Europe Cyanocobalamin Injection Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cyanocobalamin Injection Market Overview
9.3.2 Asia-Pacific Cyanocobalamin Injection Market Forecasts and Analysis
9.3.3 Asia-Pacific Cyanocobalamin Injection Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Cyanocobalamin Injection Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Cyanocobalamin Injection Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cyanocobalamin Injection Market
9.3.5.1.1 Australia Cyanocobalamin Injection Market by Type
9.3.5.1.2 Australia Cyanocobalamin Injection Market by End User
9.3.5.2 China Cyanocobalamin Injection Market
9.3.5.2.1 China Cyanocobalamin Injection Market by Type
9.3.5.2.2 China Cyanocobalamin Injection Market by End User
9.3.5.3 India Cyanocobalamin Injection Market
9.3.5.3.1 India Cyanocobalamin Injection Market by Type
9.3.5.3.2 India Cyanocobalamin Injection Market by End User
9.3.5.4 Japan Cyanocobalamin Injection Market
9.3.5.4.1 Japan Cyanocobalamin Injection Market by Type
9.3.5.4.2 Japan Cyanocobalamin Injection Market by End User
9.3.5.5 South Korea Cyanocobalamin Injection Market
9.3.5.5.1 South Korea Cyanocobalamin Injection Market by Type
9.3.5.5.2 South Korea Cyanocobalamin Injection Market by End User
9.3.5.6 Rest of Asia-Pacific Cyanocobalamin Injection Market
9.3.5.6.1 Rest of Asia-Pacific Cyanocobalamin Injection Market by Type
9.3.5.6.2 Rest of Asia-Pacific Cyanocobalamin Injection Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cyanocobalamin Injection Market Overview
9.4.2 Middle East and Africa Cyanocobalamin Injection Market Forecasts and Analysis
9.4.3 Middle East and Africa Cyanocobalamin Injection Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Cyanocobalamin Injection Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Cyanocobalamin Injection Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cyanocobalamin Injection Market
9.4.5.1.1 South Africa Cyanocobalamin Injection Market by Type
9.4.5.1.2 South Africa Cyanocobalamin Injection Market by End User
9.4.5.2 Saudi Arabia Cyanocobalamin Injection Market
9.4.5.2.1 Saudi Arabia Cyanocobalamin Injection Market by Type
9.4.5.2.2 Saudi Arabia Cyanocobalamin Injection Market by End User
9.4.5.3 U.A.E Cyanocobalamin Injection Market
9.4.5.3.1 U.A.E Cyanocobalamin Injection Market by Type
9.4.5.3.2 U.A.E Cyanocobalamin Injection Market by End User
9.4.5.4 Rest of Middle East and Africa Cyanocobalamin Injection Market
9.4.5.4.1 Rest of Middle East and Africa Cyanocobalamin Injection Market by Type
9.4.5.4.2 Rest of Middle East and Africa Cyanocobalamin Injection Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cyanocobalamin Injection Market Overview
9.5.2 South and Central America Cyanocobalamin Injection Market Forecasts and Analysis
9.5.3 South and Central America Cyanocobalamin Injection Market Forecasts and Analysis - By Type
9.5.4 South and Central America Cyanocobalamin Injection Market Forecasts and Analysis - By End User
9.5.5 South and Central America Cyanocobalamin Injection Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cyanocobalamin Injection Market
9.5.5.1.1 Brazil Cyanocobalamin Injection Market by Type
9.5.5.1.2 Brazil Cyanocobalamin Injection Market by End User
9.5.5.2 Argentina Cyanocobalamin Injection Market
9.5.5.2.1 Argentina Cyanocobalamin Injection Market by Type
9.5.5.2.2 Argentina Cyanocobalamin Injection Market by End User
9.5.5.3 Rest of South and Central America Cyanocobalamin Injection Market
9.5.5.3.1 Rest of South and Central America Cyanocobalamin Injection Market by Type
9.5.5.3.2 Rest of South and Central America Cyanocobalamin Injection Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CYANOCOBALAMIN INJECTION MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CYANOCOBALAMIN INJECTION MARKET, KEY COMPANY PROFILES
12.1. LUITPOLD PHARMACEUTICALS (DAIICHI SANKYO)
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ENDO INTERNATIONAL
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BRISTOL-MYERS SQUIBB
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SANOFI-AVENTIS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JAMIESON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TEVA (ACTAVIS)
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MYLAN
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BAYER HEALTHCARE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PFIZER
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Luitpold Pharmaceuticals (Daiichi Sankyo)
2. Endo International
3. Bristol-Myers Squibb
4. Sanofi-Aventis
5. Jamieson
6. Teva (Actavis)
7. Merck
8. Mylan
9. Bayer HealthCare
10. Pfizer
11. ANGELINI
12. Biological E
13. CCEPCD
14. Huaxin Pharmaceutical
TIPRE00021886
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.